Evidence‐based veterinary medicine in finfish aquaculture in Newfoundland



























































Department:   HealthManagement
Degree:   DoctorofPhilosophy   Year: 2012
In presenting this thesis in partial fulfillment of the requirements for a postgraduate degree
from theUniversityofPrinceEdward Island, I agree that the Librariesof thisUniversitymay
makeitfreelyavailableforinspection. Ifurtheragreethatpermissionforextensivecopyingof
thisthesisforscholarlypurposesmaybegrantedbytheprofessororprofessorswhosupervised








  Address: Dept.ofHealthManagement
  AtlanticVeterinaryCollege
       UniversityofPrinceEdwardIsland
       550UniversityAvenue
       Charlottetown,PEC1A4P3
       CANADA.











































































































































































































































































































































































ATPase   AdenosineTriphosphate
BA   BloodAgar
BMA   BayManagementArea
CHSE214  ChinookSalmonEmbryo214
CI   ConfidenceInterval 
EBM   Evidence ?BasedMedicine
EBVM   Evidence ?BasedVeterinaryMedicine
FAO   FoodandAgricultureOrganization
GH   GrowthHormone
H&E   HematoxylinandEosin
HOBr   HypobromousAcid
HPLC   HighPerformanceLiquidChromatography
HR   HazardRatio
NL   NewfoundlandandLabrador
NLDFA   NewfoundlandandLabradorDepartmentofFisheriesandAquaculture
NNV   NervousNecrosisVirus
OIE   WorldHealthOrganization
PIT   PassiveIntegratedTransponders
RCT   RandomizedControlledTrials
RDVS ?AVC  RegionalDiagnosticVirologyServices–AtlanticVeterinaryCollege
RT ?PCR   ReverseTranscriptasePolymeraseChainReaction
Se   Sensitivity
SHK   SalmonHeadKidney
SKDM   SelectiveKidneyDiseaseMedium
Sp   Specificity
SSN ?1   StripedSnakeheadcellline
TMS   TricaineMethaneSulfonate
TSA   TrypticSoyAgar
VER   ViralEncephalopathyandRetinopathy
VI   VirusIsolation

















































































































































































































































































































1.7 Randomized controlled trials 





































































































































































































1.8.1 Evidence to support trial execution 


















1.8.2 Evidence of trials 




















































































































































































































































































Chapter 2: Passive Integrated Transponder (PIT) tag placement in Atlantic 
cod (Gadus morhua): a blinded randomized controlled trial to compare 


























































2.1 Materials and methods 
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TreatmentGroup MeanWeight(g) StandardDeviation(g) Median(g)
Control  38.4   17.9   36.0
Incision ?only  38.7   18.6   36.0







RiskFactor   HazardRatio  P ?value 95%CI1
TreatmentGroup     0.90
 Control  1
 Incision ?Only  0.95   0.70   0.73 ?1.23









Chapter 3: Survival analysis describing a nodavirus outbreak in Atlantic cod 

























































































3.1 Materials and methods 

















































































































































































































































































































Variable    Mean  St.Dev.3 Min  Max
DissolvedOxygen(%)   103.6  11.59  70  137
Temperature(°C)   10.7  0.86  9.2  12.9 
AveTemp31    10.8  0.75  9.7  12.3











RiskFactor  HazardRatio  P ?value 95%CI1
Temperature       0.008 
 9.8 ?10.8 1     ?    ? 
 10.8 ?11.3 0.55   0.004  0.36 ?0.83
 11.3 ?11.9 0.80   0.31  0.51 ?1.24








RiskFactor  HazardRatio  P ?value 95%ConfidenceInterval
Temperature       <0.001 
 9.2 ?9.8   1    ?    ? 
 9.8 ?10.1  0.78  0.20  0.53 ?1.14
 10.1 ?10.4  0.92  0.68  0.62 ?1.36  
 10.4 ?11.1  0.38  <0.001  0.24 ?0.61 
Ave3 ?dayTemperature     0.020
 9.73 ?9.97  1    ?    ?
 9.97 ?10.08  0.88  0.46  0.63 ?1.24
 10.08 ?10.33  0.69  0.08  0.46 ?1.04
 10.33 ?10.87  0.52  0.003  0.33 ?0.80
Ave3 ?daydissolvedOxygen     0.002
 86.3 ?103.8%  1    ?    ?
 103.8 ?106.3%  1.30  0.31  0.78 ?2.17
 106.3 ?109.0%  1.62  0.05  0.99 ?2.65































































0 10 20 30 40 50
time (days)
tank = 1 tank = 2
tank = 3 tank = 4









































Chapter 4: The effect of the SuperSmoltTM process on physiological 










































































4.1 Materials and methods 
























































































































































































































































































































































































































    Pre ?exposed   Control  Exposure
 Variable SP1 M2 CI3  M2 CI3  M2 CI3 
ATPase S1 7.95 6.84–8.73 5.00 4.40–6.12 7.38 6.34–8.69
ATPase S0 5.97 4.89–6.82 5.92 5.08–6.62 8.15 7.08–8.78
(umolADP/hr/mgprotein)

Osmolality S1 323.0 321.4–326.6 322.0 319.4–327.6 333.0 325.6–336.0 











Variable Group  Mean  St.Dev.1 Min Max CI2
Initialweight control  42.45  6.70  19 70 42.17–42.73
Finalweight control  223.30  52.64  50 420 221.07–225.53
Weightdiff3 control 179.89  50.15  26 363 176.78–183.00
Initialweight exposure 42.61  6.56  21 65 42.34–42.90
Finalweight exposure 212.31  48.81  60 430 210.25–214.37































Chapter 5 Randomized field trial to evaluate fenbendazole treatment 
efficacy, growth and survival of Atlantic salmon (Salmo salar) naturally 









































































5.1 Materials and methods 










































































5.1.7 Statistical analysis 
AllstatisticalanalyseswereperformedusingSTATA(Version10)software(CollegeStation,TX).
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Variable OddsRatio StandardError  95%CI1  P ?value4
5
Treatment 0.14  0.03   0.10,0.20  <0.0016
Group7
Maturation 0.34  0.11   0.18,0.65  0.0018
Status9













Days27 ?40   Days40 ?69   Days69 ?7421
OR1 SE2 P3  OR SE P  OR SE P22
23
MS4 15.72 4.08 <0.001  9.87 2.84 <0.001    >0.0524
TG5 3.32 0.90 <0.001  2.64 0.29 <0.001  2.55 0.52 <0.00125












Chapter 6 Conclusion 36










































































6.2 Evidence to support trial execution: Passive Integrated Transponder 105
























6.3 Evidence from trials 128





















































































6.3.3 Eubothrium crassum trial 208
Eubothriumcrassum,acestodefoundinthepyloriccecaeandproximalintestineofwildand209
farmedAtlanticsalmon,hasawidedistributioninmarineandfreshwaterenvironments210
(Kennedy,1978).Althoughnotquantified,theadultcestodelikelyleadstoadecreasedfeed211
conversionratio,increasedcostofproduction,extendedgrow ?outcycleandcanimpactthe212
overallhealthoftheanimal(Mitchell,1993).ThelifecycleofEubothriumcrassuminthemarine213
environmentispoorlyunderstood,anditisthoughtthatanintermediatecopepodisrequiredto214
completethelifecycle.Treatmentwithapharmacologicagentknowntoreducecestode215
numbersshouldimprovesurvivalandgrowth.Furthercollectionofevidencetosupportits216
widespreaduseinaquaculturerequiresthatalleffectsongrowthandsurvivalbeevaluatedin217
128 
 
anRCT.AnAtlanticsalmonpopulationthatwaspreviouslyPITtaggedwasdiagnosedwitha218
naturalinfectionofEubothriumcrassum.Thus,theopportunitypresenteditselftoevaluate219
treatmenteffectsbyrandomizingindividualfishtotreatmentorcontrol(notreatment).220
221
Thestudyconcludedthattreatmentwithfenbendazoleat5mg ?kg ?1ondays1and4was222
effectiveatreducingtheprevalenceofnaturallyoccurringEubothriumcrassumatamarinecage223
siteinNL.However,theresultsfromthisstudydemonstratedadifferentialmortalityinthe224
treatedgroupandapossibleinteractionbetweentreatmentandconcurrentdisease.Although225
thistrialconfirmsthatEubothriumprevalenceisreducedbyfenbendazoletreatment,italso226
confirmstheneedtoexamineallevidencerelatedtobenefitsandpossibleadverseeffects.227
Concurrentdiseaseinteractionsaredifficulttoexploreunderfieldconditions,butmortality228
outcomesshouldhavebeensimilarinbothgroupsbasedonrandomizationevenlydistributing229
anyimmeasurableconfounders.Thefactthatmortalitywasgreaterintreatedfishsuggeststhat230
thistreatmentshouldnotbeassumedentirelybeneficialunderallcircumstances.Futureuseof231
thisproductmustbeconsideredwiththispossiblenegativesideeffect.Thisstudyhighlighted232
theneedofRCTandtheiruseinEBVM.233
 234
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